Clinical Trial

The German ADPKD Tolvaptan Treatment Registry

Study acronym: AD(H)PKD
Recruiting
View on ClinicalTrials.gov →
Summary
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2015-07-09; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2015-11-16
Trial Details
NCT Number NCT02497521
Lead Sponsor University of Cologne
Conditions ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Enrollment 2,000 participants
Start Date 2015-11
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-30